# Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry

> **NCT04587388** · — · RECRUITING · sponsor: **European Hematology Association - Lymphoma Group** · enrollment: 500 (estimated)

## Conditions studied

- Follicular Lymphoma
- Relapsed/Refractory Follicular Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04587388
- **Lead sponsor:** European Hematology Association - Lymphoma Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-22
- **Primary completion:** 2023-05-22
- **Final completion:** 2026-05-22
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-10-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04587388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04587388, "Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04587388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*